Retatrutide 10mg

Retatrutide 10 mg — Research Peptide

Retatrutide is a next-generation triple-agonist research peptide that activates GLP-1, GIP and glucagon receptors simultaneously. This unique triple-receptor activity makes it the most potent GLP-1-based compound in current clinical research.

Product Details

• Net weight: 10 mg (lyophilised)
• Purity: ≥98.9% (HPLC-verified)
• Identity confirmed by LC-MS
• Batch-specific COA included

Receptor Targets

• GLP-1 Receptor (Glucagon-like Peptide-1)
• GIP Receptor (Glucose-dependent Insulinotropic Polypeptide)
• Glucagon Receptor

For research purposes only. Not intended for human use.